ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Imara Announces Launch of Proposed Public Offering
July 14, 2021Imara Inc. (the "Company") (Nasdaq: IMRA) today announced that it has commenced a proposed underwritten public offering of $50 million of shares of its common stock. All of the shares are being offered by the Company. -
Imara Announces FDA Fast Track Designation for IMR-687 for Sickle Cell Disease
May 30, 2019Imara announced the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to IMR-687, the company’s lead product candidate for the treatment of sickle cell disease.
Pharma Sources Insight January 2025
